Literature DB >> 316308

Effect of inoculum size on the susceptibility of Haemophilus influenzae b to beta-lactam antibiotics.

V P Syriopoulou, D W Scheifele, C M Sack, A L Smith.   

Abstract

The current prevalence of ampicillin-resistant Haemophilus influenzae b meningitis requires accurate knowledge of susceptibility to alternative antibiotics. One variable affecting susceptibility is inoculum size. We studied the susceptibility of 200 clinical isolates of H. influenzae b to ampicillin, carbenicillin, and cefamandole at inocula of 10(5) and 10(7) CFU by two techniques. Fifty ampicillin-susceptible and fifty ampicillin-resistant strains were tested for susceptibility to ampicillin by broth dilution while 100 of each were tested by agar dilution. An inoculum effect was found, being greatest with the ampicillin-resistant strains. The range of minimal inhibitory concentrations for the resistant strains was 25 to 800 microgram of ampicillin per ml at an inoculum of 10(5) and 2,000 to less than 6,000 microgram of ampicillin at 10(7); 1.0 to 150 microgram of carbenicillin per ml at 10(5) and 6.2 to 2,000 microgram of carbenicillin per ml at 10(7); 0.4 to 2.0 microgram of cefamandole at 10(5) and 1.0 to 125 microgram/ml at 10(7). Because of this inoculum effect, we would not recommend the use of carbenicillin or cefamandole for therapy of ampicillin-resistant H. influenzae meningitis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 316308      PMCID: PMC352890          DOI: 10.1128/AAC.16.4.510

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Antibiotics and invasive Haemophilus influenzae.

Authors:  A L Smith
Journal:  N Engl J Med       Date:  1976-06-10       Impact factor: 91.245

2.  Concentrations of bacteria in cerebrospinal fluid of patients with bacterial meningitis.

Authors:  W E Feldman
Journal:  J Pediatr       Date:  1976-04       Impact factor: 4.406

3.  Susceptibility of Hemophilus influenzae to 21 antibiotics in vitro.

Authors:  H A HIRSCH; M FINLAND
Journal:  Am J Med Sci       Date:  1960-01       Impact factor: 2.378

4.  PENICILLIN-RESISTANT STAPHYLOCOCCI: MECHANISMS INVOLVED IN THE DEVELOPMENT OF RESISTANCE.

Authors:  W W Spink; V Ferris
Journal:  J Clin Invest       Date:  1947-05       Impact factor: 14.808

5.  Transferable chloramphenicol and ampicillin resistance in a strain of Haemophilus influenzae.

Authors:  L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1978-07       Impact factor: 5.191

6.  Osmotically stable L forms of Haemophilus influenzae and their significance in testing sensitivity to penicillins.

Authors:  J R May; D E Roberts; A Ingold; S V Want
Journal:  J Clin Pathol       Date:  1974-07       Impact factor: 3.411

7.  Antimicrobial susceptibility of Hemophilus influenzae.

Authors:  S E McLinn; J D Nelson; K C Haltalin
Journal:  Pediatrics       Date:  1970-05       Impact factor: 7.124

8.  Failure of cefamandole in treatment of meningitis due to Haemophilus influenzae type b.

Authors:  E A Steinberg; G D Overturf; J Wilkins; L J Baraff; J M Streng; J M Leedom
Journal:  J Infect Dis       Date:  1978-05       Impact factor: 5.226

9.  Evaluation of a rapid beta-lactamase test for detecting ampicillin-resistant strains of Hemophilus influenzae type b.

Authors:  D W Scheifele; V P Syriopoulou; A L Harding; B B Emerson; A L Smith
Journal:  Pediatrics       Date:  1976-09       Impact factor: 7.124

10.  Hemophilus influenzae type B susceptibility to 17 antibiotics.

Authors:  B B Emerson; A L Smith; A L Harding; D H Smith
Journal:  J Pediatr       Date:  1975-04       Impact factor: 4.406

View more
  21 in total

Review 1.  Haemophilus influenzae: antibiotic susceptibility.

Authors:  C A Needham
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

Review 2.  Serum bactericidal test.

Authors:  C W Stratton
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

3.  Bacterial counts in cerebrospinal fluid of children with meningitis.

Authors:  E Bingen; N Lambert-Zechovsky; P Mariani-Kurkdjian; C Doit; Y Aujard; F Fournerie; H Mathieu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

Review 4.  Mechanisms of beta-lactam resistance in Haemophilus influenzae.

Authors:  L Gutmann; R Williamson; E Collatz; J F Acar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-10       Impact factor: 3.267

Review 5.  Antimicrobial susceptibility testing of Haemophilus influenzae, Branhamella catarrhalis, and Neisseria gonorrhoeae.

Authors:  G V Doern; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

6.  Ampicillin killing curve patterns for ampicillin-susceptible nontypeable Haemophilus influenzae strains by the agar dilution plate count method.

Authors:  B F Woolfrey; M A Enright
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

7.  Molecular characterization of three chloramphenicol acetyltransferases isolated from Haemophilus influenzae.

Authors:  M Roberts; A Corney; W V Shaw
Journal:  J Bacteriol       Date:  1982-08       Impact factor: 3.490

8.  In vitro activity of second and third generation cephalosporins against ampicillin susceptible and resistant haemophilus influenzae.

Authors:  J L Burns; K Wong; A L Smith
Journal:  Infection       Date:  1988 Sep-Oct       Impact factor: 3.553

9.  Effects of various test media on the activities of 21 antimicrobial agents against Haemophilus influenzae.

Authors:  Michael R Jacobs; Saralee Bajaksouzian; Anne Windau; Peter C Appelbaum; Gengrong Lin; David Felmingham; Christine Dencer; Laura Koeth; Mendel E Singer; Caryn E Good
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

10.  Broth microdilution testing of Haemophilus influenzae with haemophilus test medium versus lysed horse blood broth. Canadian Haemophilus Study Group.

Authors:  S R Scriver; D E Low; A E Simor; B Toye; A McGeer; R Jaeger
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.